HY-P99994-1mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
HY-P99994-10mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
HY-P99994-5mg
|
MedChemexpress LLC
|
Human IgG1 (N297A) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
HY-P99998-1mg
|
MedChemexpress LLC
|
Human IgG1 (F405L) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
HY-P99998-5mg
|
MedChemexpress LLC
|
Human IgG1 (F405L) Kappa , Isotype Control
|
|
COVID-19-immunoregulation
|
|
HY-P99999-1mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
HY-P99999-10mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
HY-P99999-5mg
|
MedChemexpress LLC
|
Anti-Mouse CD4 Antibody (YTS 191)
|
|
|
|
HY-W877850-100mg
|
MedChemexpress LLC
|
Mal-C5-N-bis(PEG2-C2-acid)
|
|
|
|
HY-W877850-25mg
|
MedChemexpress LLC
|
Mal-C5-N-bis(PEG2-C2-acid)
|
|
|
|
HY-W877850-50mg
|
MedChemexpress LLC
|
Mal-C5-N-bis(PEG2-C2-acid)
|
|
|
|
HY-132258-1mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine [CAS 1453084-37-1]
|
|
Cancer-programmed cell death
|
|
HY-132258-5mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine [CAS 1453084-37-1]
|
|
Cancer-programmed cell death
|
|
HY-132258A-1mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine (solution) [CAS 1453084-37-1]
|
|
|
|
HY-132258A-5mg
|
MedChemexpress LLC
|
Mirvetuximab soravtansine (solution) [CAS 1453084-37-1]
|
|
|
|